Filing Details
- Accession Number:
- 0001437749-24-027058
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-08-16 08:01:30
- Reporting Period:
- 2024-08-15
- Accepted Time:
- 2024-08-16 08:01:30
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 749647 | Imunon Inc. | IMNN | Pharmaceutical Preparations (2834) | 521256615 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1384550 | H Michael Tardugno | C/O Imunon, Inc. 997 Lenox Drive, Suite 100 Lawrenceville NJ 08648 | Executive Chairman Of Board | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Imunon Common Stock | Acquisiton | 2024-08-15 | 25,000 | $1.03 | 353,346 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- The Chairman purchased the stock on the open market.
Billionaire Hedge Funds
